Becton, Dickinson and Company (BDX)の価格はいくらですか

Becton, Dickinson and Company (BDX)の価格は$183.43です

Becton, Dickinson and Company (BDX)の時価総額は何ですか

Becton, Dickinson and Company (BDX)の時価総額は$50.54Bです

Becton, Dickinson and Company（BDX）営業利益率

Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.

年	営業利益率	変化
2026 (TTM)	9.83%	-16.69%
2025	11.80%	-0.67%
2024	11.88%	8.99%
2023	10.90%	-9.84%
2022	12.09%	2.81%
2021	11.76%	107.41%
2020	5.67%	-44.30%
2019	10.18%	7.84%
2018	9.44%	-25.02%
2017	12.59%	9.86%
2016	11.46%	9.67%
2015	10.45%	-45.03%
2014	19.01%	22.09%
2013	15.57%	-22.96%
2012	20.21%	-8.01%
2011	21.97%	-1.08%
2010	22.21%	-2.37%
2009	22.75%	4.74%
2008	21.72%	14.80%
2007	18.92%	-4.88%
2006	19.89%	4.52%
2005	19.03%	19.31%
2004	15.95%	-6.45%
2003	17.05%	0.12%
2002	17.03%	-0.99%
2001	17.20%	8.72%
2000	15.82%	0.00%

年

営業利益率

変化

2026 (TTM)

9.83%

-16.69%

2025

11.80%

-0.67%

2024

11.88%

8.99%

2023

10.90%

-9.84%

2022

12.09%

2.81%

2021

11.76%

107.41%

2020

5.67%

-44.30%

2019

10.18%

7.84%

2018

9.44%

-25.02%

2017

12.59%

9.86%

2016

11.46%

9.67%

2015

10.45%

-45.03%

2014

19.01%

22.09%

2013

15.57%

-22.96%

2012

20.21%

-8.01%

2011

21.97%

-1.08%

2010

22.21%

-2.37%

2009

22.75%

4.74%

2008

21.72%

14.80%

2007

18.92%

-4.88%

2006

19.89%

4.52%

2005

19.03%

19.31%

2004

15.95%

-6.45%

2003

17.05%

0.12%

2002

17.03%

-0.99%

2001

17.20%

8.72%

2000

15.82%

0.00%

企業	営業利益率	営業利益率の差	国
Intuitive Surgical, Inc. ISRG.US	31.28%	-96.82%	US
EssilorLuxottica S.A. EL.PA	12.36%	-98.74%	FR
HOYA Corporation 7741.T	0.00%	-	JP
Alcon Inc. ALC.SW	0.00%	-	CH
Medline Inc. MDLN.US	0.00%	-	US

企業

営業利益率

営業利益率の差

国